Datavault AI Licenses Technology to Wellgistics Health to Combat PBM-Driven Drug Pricing Inefficiencies

▤ Summary

Datavault AI granted Wellgistics Health an exclusive patent license to its PharmacyChain platform and related proprietary technologies to address PBM-driven prescription pricing inefficiencies. The platform tracks prescription fulfillment end-to-end, automates processes typically handled by PBMs, and provides real-time data to improve transparency and pricing. Wellgistics will integrate the technology across its network with exclusivity in its market segment to drive commercial adoption. The move positions Datavault AI to expand into healthcare while offering a tech-driven alternative to traditional PBM intermediaries that could lower costs for patients and payers.

▦ Linked Companies